Evaluation of the Effectiveness and Safety of ABAStroke

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

Also called NCT05979324

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
ABAStroke Sp. z o.o. (from the registry)
Registry
  • NCT NCT05979324
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Poland (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05979324. Randomized; no masking; primary purpose treatment. Start 2023-07-13 (actual); primary completion 2023-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Evaluation of the Effectiveness and Safety of ABAStroke
Condition
Stroke
Intervention (Device)
ABAStroke Digital Therapeutics
Lead sponsor
ABAStroke Sp. z o.o. (class: industry)

Record details

Record id
cardio:ct-nct05979324
Content hash
8de4b448f4e90b978eadaacb59d8eb7192a8d510bd796501016d8b72700a065d